Abstract

ObjectiveThere is no consensus on the best choice between high- and low-viscosity bone cement for percutaneous vertebroplasty (PVP). This study aimed to compare the clinical and radiological outcomes and leakage between three cements with different viscosities in treating osteoporotic vertebral compression fractures.MethodsThis is a prospective study comparing patients who were treated with PVP under local anesthesia: group A (n = 99, 107 vertebrae) with high-viscosity OSTEOPAL V cement, group B (n = 79, 100 vertebrae) with low-viscosity OSTEOPAL V cement, and group C (n = 88, 102 vertebrae) with low-viscosity Eurofix VTP cement. Postoperative pain severity was evaluated using the visual analog scale. Cement leakage was evaluated using radiography and computed tomography.ResultsThere was no significant difference in the incidence of cement leakage between the three groups (group A 20.6%, group B 24.2%, group C 20.6%, P = 0.767). All three groups showed significant reduction in postoperative pain scores but did not differ significantly in pain scores at postoperative 2 days (group A 2.01 ± 0.62, group B 2.15 ± 0.33, group C 1.92 ± 0.71, P = 0.646). During the 6 months after cement implantation, significantly less reduction in the fractured vertebral body height was noticed in group B and group C than in group A (group A 19.0%, group B 8.1%, group C 7.3%, P = 0.009).ConclusionsLow-viscosity cement has comparable incidence of leakage compared to high-viscosity cement in PVP for osteoporotic vertebral compression fractures. It also can better prevent postoperative loss of fractured vertebral body’s height.

Highlights

  • Polymethyl methacrylate (PMMA) bone cement is used in percutaneous vertebroplasty (PVP) for the treatment of osteoporotic vertebral compression fractures

  • The inclusion criteria were as follows: (1) osteoporotic vertebral compression fracture confirmed by imaging examination, (2) back pain evaluated by visual analog scale above 4 points, (3) bone edema in the fractured vertebra on magnetic resonance imaging (MRI): high signal in T2weighted images and short tau inversion recovery sequences and low signal in T1-weighted images, (4) age over 50 years; and (5) decreased bone mineral density (T scores < − 1) shown by densitometry

  • The three groups showed no significant difference in the incidence of cement leakage

Read more

Summary

Introduction

Polymethyl methacrylate (PMMA) bone cement is used in percutaneous vertebroplasty (PVP) for the treatment of osteoporotic vertebral compression fractures. It is injected into the fractured vertebral body to achieve immediate augmentation, relief of the pain, and patient mobility improvement. The viscosity of the cement paste increases with advancement of polymerization of PMMA until it solidifies. The cement is implanted into the fractured vertebra using an injection gun immediately after mixing, when it still has a low viscosity and is easy to aspirate. We speculate that low-viscosity cement may reduce the risk of leakage and have better filling in the vertebral trabeculae and prevent postoperative loss of vertebral height

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call